Major Advance in Gene Therapy for Hemophilia B
As reported by the New York Times on December 10th and by a wide variety of other media outlets, medical researchers in Britain have successfully used gene therapy to treat six individuals with Factor IX deficiency also known as hemophilia B. The results represent a major advance not only in the treatment of hemophilia but also in the field of gene therapy which has experienced many setbacks and false starts over the last twenty years.
